Clinical Trials Browser

Phase 2 × OTHER × Other Cancer × Clear all

NCT03674047 2025-11-10

Ruxolitinib for Bronchiolitis Obliterans Syndrome (BOS) After Allogeneic Hematopoietic Cell Transplantation (HCT)

Phase 2 Active not recruiting

Other Cancer